Consultation on use patterns for anticoagulant rodenticide products

This consultation closed on 17 July 2020

Consultation period

7 April 2020 to 17 July 2020
The Australian Pesticides and Veterinary Medicines Authority (APVMA) sought comments from interested stakeholders on use patterns for anticoagulant rodenticide products, in a consultation that closed on 17 July 2020.

Of the submissions received, 3,327 were campaign form emails, and a further 84 were from government agencies, holders, retailers, stakeholders or individuals. Copies of the published submissions (part 1, part 2, part 3 and part 4) and a summary of the submissions received are available on our website.

On 2 November 2021, the APVMA issued a notice to commence a reconsideration of anticoagulant rodenticides. More information about the review is available on our website.

Key issues

  1. Products considered anticoagulant rodenticides have been prioritised for reconsideration on the basis of concerns for worker exposure, public health and environmental safety.
  2. The use of products in domestic premises, animal production facilities and food production facilities is currently allowed.
  3. International jurisdictions (including the United States Environmental Protection Agency and the European Chemicals Agency) have taken action to limit access to these products by non-professional users, and to restrict the product formulations available and the situations in which these products may be used.
  4. The APVMA is consulting with the states and territories and relevant holders regarding the registered particulars and conditions of use for anticoagulant rodenticide products. This does not include the intentional misuse of the products, not in accordance with the label instructions.

Focus of the consultation

Registered products containing the following active constituents are included in this consultation:

First-generation anticoagulant rodenticides (FGARs):

  • warfarin
  • coumatetralyl
  • diphacinone

Second-generation anticoagulant rodenticides (SGARs):

  • brodifacoum
  • bromadiolone
  • difenacoum
  • difethialone
  • flocoumafen


  1. During this consultation, the APVMA welcomes submissions on matters related to:

a. The need for anticoagulant rodenticide products to be used in home garden or domestic settings;
b. The need for anticoagulant rodenticide products to be used in residential or suburban settings, for example, for public health or public sanitation programs;
c. The need for anticoagulant rodenticide products to be used in or around buildings, including those used to house livestock, or in or around on-farm buildings (including homesteads);
d. The need for anticoagulant rodenticide products to be formulated as powders, gels, liquids, pellets, grains or pastes;
e. The likelihood of compliance with post-application sanitisation instruction (eg the timely collection of poisoned rodent carcasses, and the appropriate disposal of carcasses);
f. The label instructions, particularly the adequacy of instructions to prevent inadvertent exposure to the product;
g. Critical uses for anticoagulant rodenticide products, particularly in primary production; and,
h. Other relevant matters related to the use of anticoagulant rodenticide products.

Written submissions are invited

  1. The deadline for submissions is 17 July 2020. Electronic submissions are preferred, and submissions with an email address will be acknowledged electronically.
  2. Note that all submissions received are subject to legislation, including the Freedom of Information Act 1982, the Privacy Act 1988 and the Agvet Codes. In providing your submission to the APVMA, you agree to the APVMA publicly disclosing your submission in whole or summary form. Submissions should not contain confidential commercial information.

Questions and submissions should be directed to:

Chemical Review
Office of the Chief Regulatory Scientist
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262, Sydney NSW 2001, Australia
Telephone: +61 2 6770 2400

Was this page helpful?

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.